相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CYPIBI expression is induced by docetaxel: effect on cell viability and drug resistance
V. G. Martinez et al.
BRITISH JOURNAL OF CANCER (2008)
被撤回的出版物: Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor (Retracted article. See vol. 18, pg. 869, 2019)
Shu-Chuan Weng et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The combination of epigallocatechin gallate and curcumin suppresses ERα-breast cancer cell growth in vitro and in vivo
Tiffany J. Somers-Edgar et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer
Christina Justenhoven et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Synergistic cytotoxic effects of tamoxifen and black cohosh on MCF-7 and MDA-MB-231 human breast cancer cells: an in vitro study
Mahera Ai-Akoum et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2007)
Cellular responses to EGFR inhibitors and their relevance to cancer therapy
Pinaki R. Dutta et al.
CANCER LETTERS (2007)
Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor α expression reversing invasive phenotype of breast cancer cells
Karine Belguise et al.
CANCER RESEARCH (2007)
A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent
Kristin R. Landis-Piwowar et al.
CANCER RESEARCH (2007)
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo
Rajesh L. Thangapazham et al.
CANCER LETTERS (2007)
The combination of green tea and tamoxifen is effective against breast cancer
Maryam R. Sartippour et al.
CARCINOGENESIS (2006)
Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma
Yan Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
When translation meets transformation: the mTOR story
J. Averous et al.
ONCOGENE (2006)
Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma
RM Gemmill et al.
BRITISH JOURNAL OF CANCER (2005)
Signaling through the epidermal growth factor receptor during the development of malignancy
JR Grandis et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells
K Chisholm et al.
ANTI-CANCER DRUGS (2004)
NF-KB activation in human breast cancer specimens and its role in cell proliferation and apoptosis
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cytochrome P4501B1: a target for inhibition in anticarcinogenesis strategies
FP Guengerich et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2003)
Vascular endothelial growth factor in breast cancer: Biologic and therapeutic aspects
GW Sledge
SEMINARS IN ONCOLOGY (2002)
Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro
V Tanos et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2002)
Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry
CA Li et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Green tea and its catechins inhibit breast cancer xenografts
MR Sartippour et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2001)
分享论文
